4//SEC Filing
Golembiewski Michael Joseph 4
Accession 0001136261-22-000155
CIK 0001017491other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 4:02 PM ET
Size
4.9 KB
Accession
0001136261-22-000155
Insider Transaction Report
Form 4
Golembiewski Michael Joseph
Chief Financial Officer
Transactions
- Award
Common Stock
2022-02-28$0.90/sh+12,500$11,263→ 78,487 total
Footnotes (1)
- [F1]These shares were acquired under the Company's 2020 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Documents
Issuer
SEELOS THERAPEUTICS, INC.
CIK 0001017491
Entity typeother
Related Parties
1- filerCIK 0001639479
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 4:02 PM ET
- Size
- 4.9 KB